Please wait
skip to Main Content
Special Journals Publisher - SJP - PIC - +256700488917
Excellence beyond Expectations


Please read [**Our APC WAIVERS terms** before you submit your papers

    Manuscript Details

    Submission guide

    Pathology, Immunology, and Cancer research papers can be submitted to the Special Journal of Pathology, Immunology, and Cancer for attention. To submit a manuscript to the, we recommend the use of strobes guidelines or checklist as adapted from the strobe guideline for observational studies (STROBES) as indicated here  If you can say yes to all the questions, then you are ready to submit your manuscript for consideration. You are advised to use the form above to submit your manuscript for consideration and publication in the Special Journal of Pathology, Immunology, and Cancer. We need only word format so it can be easy to put in the reviewer’s comments using track changes.

    For submission of a non-observational study manuscript, you are advised to follow the authors’ information to comply with our writing format so as to pass editorial screening before papers are sent for external peer review! If the editorial office is not satisfied, your manuscript may be returned to you for attention within 48hrs! Thank you for choosing to publish with us.

    Adapted from the
    strobe guideline for observational studies (STROBES)

    S/N Section Question answer
    1 Title and abstract: Study’s design in the title/abstract indicated
    2 Background/Rationale: Informative/balanced summary of methods and key results provided in
    the abstract
    3. Objective: Scientific background and rationale for reported investigation
    clearly explained
    4. Study design: Key elements of study design presented
    5. Setting: The setting, locations, dates, periods of recruitment, exposure,
    follow-up, and data collection clearly described
    6. Participants: Study type, Eligibility/matching criteria, participants selection,
    case ascertainment, control  and follow
    up methods/source, number of exposed, unexposed,  and controls per case
    7. Variables: All outcomes, exposures, predictors, potential confounders, and
    effect modifiers; diagnostic criteria, clearly defined
    8. Data source/measurement:  Sources of data, methods of
    assessment (measurement); describe comparability of assessment method(s) given
    in detail
    9 Bias: Efforts to address likely sources of bias defined
    10. Study size: How the study size was derived clearly outlined
    11. Quantitative variables How quantitative variables were analyzed include which groupings were
    chosen and why
    12. Statistical methods: All statistical methods, including those used to: control for
    confounding, examine subgroups and interactions, address missing data, loss
    to follow-up, matching of cases and controls, analyze  sampling strategy and sensitivity  explained
    13 Participants: Numbers of individuals potentially, examined or confirmed eligible at
    each stage of the study and those included in the study or completing
    follow-up, and reasons for nonparticipation are clearly defined,   Consider
    use of a flow diagram
    14. Descriptive data: Characteristics of study participants (e.g., demographic, clinical,
    social) and information on exposures and potential confounders, number of
    participants with missing data for each variable of interest, summarize
    follow-up time (e.g., average and total amount) clearly defined
    15. Outcome data: Numbers of outcome events or summary measures over time, numbers in
    each exposure category, or summary measures of exposure and  numbers of outcome events or summary
    measures, outlined
    16. Main results: Have you given unadjusted estimates and, if applicable,
    confounder-adjusted estimates and their precision (e.g., 95% confidence
    interval); make clear which confounders were adjusted for and why they were
    included, report category boundaries when continuous variables were
    17 Other analysis: Subgroups, interactions, and sensitivities reported
    18. Key results: Key results in relation to study objectives reported
    19 Limitation: limitations of the study, taking into account sources of potential
    bias or imprecision; discuss both direction and magnitude of any potential
    20. Interpretation: Give a cautious overall interpretation of results considering objectives,
    limitations, multiplicity of analyses, results from similar studies, and
    other relevant evidence
    21 Generalizability: Discuss the generalizability (external validity) of the study results
    22. Funding: the source of funding and the role of the funders for the present
    study and, if applicable, for the original study on which the present article
    is based  Funding

    Submit with the form above

    If you have answered yes to all the questions indicated in the above checklist you are now ready to submit your manuscript. Just fill the forms and attach the file of not more than 5mb to submit. Accepted format include word document only



    Back To Top
    We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.